8AA-43807-33313
4 vaccinations
10 coded responses
29 check-ins
10 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 907 / CA
- Registered
- 2021-11-16
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Moderna
-
2021-05-05
Dose 2 — Moderna
-
2021-11-16
Registered in v-safe
-
2021-11-16
Dose 3 — Moderna
-
2021-11-16
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Fatigue or tirednessAdult check-in
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-23
Health check-in — day 7, dose 3Feeling: Fair · Site: Swelling · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-01
-
2021-12-07
Survey response — day 21, dose 3MedDRA: Aphonia, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold like symptoms. Loss voiceMedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Survey response — day 28, dose 3MedDRA: Aphonia, Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Cold lost voiceMedDRA releases: 2024-11 · check-in free text available
- 2021-12-21
- 2021-12-28
-
2022-02-17
Survey response — 3 months, dose 3MedDRA: Arthritis, Bursitis, Pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: It relates to bursitis and arthritis. PainMedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-21
-
2022-02-22
Call successfulParticipant prefers to complete VAERS report online
- 2022-05-17
-
2022-05-23
Dose 4 — Moderna
-
2022-05-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-26
Survey response — days 1–6 daily, dose 4MedDRA: Axillary mass, Axillary pain, Joint range of motion decreased — Feeling: Fair · Site: Pain, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Small lump and pain in axilla shoulder with loss of range of motionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Survey response — days 1–6 daily, dose 4MedDRA: Axillary mass, Axillary pain, Injection site swelling — Feeling: Fair · Site: Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Axilla pain and lump. Pea size bump at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-05-28
Survey response — days 1–6 daily, dose 4MedDRA: Axillary mass, Axillary pain, Injection site mass — Feeling: Fair · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Small pea sized lump and injection site lump and axilla with pain.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-30
Survey response — day 7, dose 4MedDRA: Arthralgia, Axillary pain, Injection site mass, Mobility decreased — Feeling: Fair · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Pea size lump at site. Axilla and shoulder painful. Decrease range of motion.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-06
-
2022-06-13
Survey response — day 21, dose 4MedDRA: Arthropathy, Joint range of motion decreased, Muscle disorder, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: My arm is still with decreased range of motion. And has increased in pain. Seems to be from the joint and the muscles.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-20
Survey response — day 28, dose 4MedDRA: Arthralgia, Joint range of motion decreased, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Arm joint muscle still at times worst than other times. Pain and range of motionMedDRA releases: 2024-11 · check-in free text available
- 2022-06-29
- 2022-07-06
-
2022-08-22
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid with rebound. Used the L antiviralMedDRA releases: 2024-11 · check-in free text available
-
2022-08-22
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-23
- 2022-08-23
-
2022-08-23
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-22
- 2023-05-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Moderna | No |
| 2 | 2021-05-05 | Moderna | No |
| 3 | 2021-11-16 | Moderna | No |
| 4 | 2022-05-23 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 10 — day 21, dose 3
Symptoms: Cold like symptoms. Loss voice
Release 10 — day 28, dose 3
Symptoms: Cold lost voice
Release 11 — 3 months, dose 3
Symptoms: It relates to bursitis and arthritis. Pain
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Small lump and pain in axilla shoulder with loss of range of motion
Systemic reaction (other): Axilla pain and lump. Pea size bump at injection site
Systemic reaction (other): Small pea sized lump and injection site lump and axilla with pain.
Release 11 — day 7, dose 4
Systemic reaction (other): Pea size lump at site. Axilla and shoulder painful. Decrease range of motion.
Release 12 — day 21, dose 4
Symptoms: My arm is still with decreased range of motion. And has increased in pain. Seems to be from the joint and the muscles.
Release 12 — day 28, dose 4
Symptoms: Arm joint muscle still at times worst than other times. Pain and range of motion
Release 12 — 3 months, dose 4
Symptoms: Covid with rebound. Used the L antiviral
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Arthropathy | · | · | ✓ |
| SD | Bursitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Joint range of motion decreased | · | · | ✓ |
| SD | Muscle disorder | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Axillary mass | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Injection site mass | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Joint range of motion decreased | · | · | ✓ |
| SRO | Mobility decreased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release